Fulcrum Therapeutics, Inc.
Fulcrum Therapeutics, Inc.（FULC）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
fulc · 股价预测 · 17 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 17 位华尔街分析师
Buy
17 位分析师
共识
评级分布
12 个月目标价
High
$4.00
Consensus
$3.60
+3.3% upside
Low
$3.00
Median: $4 · Last Close: $3.48
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$3.60
3.3% upside
High Target
$4
14.8%
Low Target
$3
-13.9%
Current Price
$3.48
as of today
Based on analyst price targets, the FULC stock price prediction for the next 12 months ranges from $3 to $4. The consensus FULC price forecast of $3.60 implies 3.3% upside from the current price of $3.48.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $3.49 | ↑ 0.00% |
1-day model range: $3.45–$3.52. Peak: $3.52 (+0.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · FULC · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-03 | JP Morgan | Downgrade ↓ | Overweight→Underweight |
| 2026-06-02 | Piper Sandler | Downgrade ↓ | Overweight→Underweight |
| 2026-06-02 | Truist Securities | Downgrade ↓ | Buy→Hold |
| 2026-06-02 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2026-06-02 | Stifel | Downgrade ↓ | Buy→Hold |
| 2026-06-02 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-12-11 | Truist Securities | Maintains | Buy→Buy |
| 2025-12-09 | B of A Securities | Maintains | Underperform→Underperform |
| 2025-12-08 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2025-12-08 | Piper Sandler | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Fulcrum Therapeutics, Inc. (FULC) stock. Of the recent 86 rating actions, 9 were upgrades and 19 were downgrades. 17 analysts currently cover FULC.
分析师推荐趋势
FULC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 99.4% YoY
Revenue Next Year
$361M
↑ 115722.9% YoY
EPS This Year
$-0.81
EPS Next Year
$-0.65
↓ 19.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast FULC EPS of $-0.81 for the current fiscal year, based on estimates from 9 analysts. The FULC revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
FULC 股价预测由两类独立数据源支撑：来自 17 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。FULC 的共识目标价为 $3.60（+3.3% 上行空间），分析师共识为 Buy。
FULC 的短期预测（明日）为 $3.49（+0.00%）。
Fulcrum Therapeutics, Inc. 在 NASDAQ 上市，代码 FULC。FULC 在 2027 年的整体展望偏积极，在覆盖分析师中约 41% 对应 Buy 共识。
常见问题
FULC 预测 · 8 个问题根据 17 位华尔街分析师，FULC 的 12 个月平均目标价为 $3.60，最高 $4.00、最低 $3.00。若有图表，中位目标价可在上方查看。相对当前价 $3.48，隐含约 +3.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.